Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
drug prices
7
×
life sciences
national
national blog main
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
medicare
novartis
biogen
abbvie
alzheimer's disease
bristol-myers squibb
cancer immunotherapy
deals
gene therapy
generic drugs
merck
pfizer
What
drug
7
×
bio
roundup
prices
approval
companies
gene
lower
new
patients
pharmaceutical
plan
prescription
price
therapy
today
acquisitions
advanced
afternoon
albert
alnylam’s
alzheimer’s
anticipated
approved
atrophy
awaited
away
bff
biggest
biogen’s
biopharmaceutical
blueprint
bourla
bringing
ceo
ceos
company
conference
convo
cost
Language
unknown
unset
Current search:
" drug prices "
×
drug
×
@xconomy.com
4 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details